SHENZHEN, China--(BUSINESS WIRE)--Mindray Medical International Limited (NYSE:MR), a leading developer, manufacturer and marketer of medical devices in China, today announced the pricing of its initial public offering of 20,000,000 American Depositary Shares (ADSs) at a price to the public of US$13.50 per ADS. Each ADS represents one Class A ordinary share of Mindray. The ADSs are being listed on the New York Stock Exchange under the ticker symbol “MR”.
The offering consists of 10,643,000 ADSs to be issued by Mindray and 9,357,000 ADSs offered by the selling shareholders. To the extent that the underwriters sell more than 20,000,000 ADSs, the underwriters have an option to purchase up to an additional 2,000,000 ADSs from Mindray and up to an additional 1,000,000 ADSs from the selling shareholders. Mindray expects to use the net proceeds from this offering to construct a new headquarters building and expand its manufacturing, assembly and warehouse facilities, including the potential relocation into a new facility in Shenzhen, China, and to fund working capital and for other general corporate purposes. Mindray will not receive any of the proceeds from the sale of the ADSs by any of the selling shareholders.
Goldman Sachs (Asia) L.L.C. and UBS AG are joint bookrunners of the offering. The offering of the securities is made only by means of a prospectus, copies of which, when available, may be obtained from Goldman, Sachs & Co., c/o Prospectus Department, 85 Broad Street, New York, NY 10004, fax number: 212-902-9316, email: prospectus-ny@ny.email.gs.com, or UBS Investment Bank, Prospectus Department, c/o Clint Lauriston, 299 Park Avenue, New York, NY 10171.
Mindray’s registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission. This news release shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities law of any such state or jurisdiction.
About Mindray
Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in China with a significant and growing presence outside of China. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems. Mindray is headquartered in Shenzhen, China, and has 29 local sales and services offices in China, as well as sales and services offices in Boston, Istanbul, London and Vancouver. Contacts
Mindray Medical International Limited Joyce Hsu, 86 755 2658 2888 joyce.hsu@mindray.com.cn or Christensen Tip Fleming, 917-412-3333 tfleming@ChristensenIR.com
